申请人:Lauffer David J.
公开号:US20120165333A1
公开(公告)日:2012-06-28
The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
本发明涉及公式I的化合物,其可用于抑制c-Met蛋白激酶。本发明还提供了包含该发明化合物的药学上可接受的组合物,以及使用该组合物治疗增生性疾病的方法。